REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions

NCT02580955 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

NETWORK

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DEVICE: LEGFLOW DCB

Sponsor

Flanders Medical Research Program